These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12678466)

  • 1. Sulfonylureas and hypoglycaemia.
    Del Prato S; Aragona M; Coppelli A
    Diabetes Nutr Metab; 2002 Dec; 15(6):444-50; discussion 450-1. PubMed ID: 12678466
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients.
    Halimi S
    Diabetes Metab; 2015 Apr; 41(2):105-6. PubMed ID: 25824635
    [No Abstract]   [Full Text] [Related]  

  • 3. The place of sulfonylureas in the therapy for type 2 diabetes mellitus.
    Del Prato S; Pulizzi N
    Metabolism; 2006 May; 55(5 Suppl 1):S20-7. PubMed ID: 16631807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review.
    Burge MR; Sood V; Sobhy TA; Rassam AG; Schade DS
    Diabetes Obes Metab; 1999 Jul; 1(4):199-206. PubMed ID: 11228754
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-acting sulfonylureas -- long-acting hypoglycaemia.
    Veitch PC; Clifton-Bligh RJ
    Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.
    Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR
    Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide treatment for sulfonylurea-induced hypoglycaemia.
    Crawford BA; Perera C
    Med J Aust; 2004 May; 180(10):540-1; author reply 541. PubMed ID: 15139835
    [No Abstract]   [Full Text] [Related]  

  • 8. [Present status in the treatment of type 2 diabetes mellitus. Insulin-secreting agents].
    Blicklé JF; Andres E; Neyrolles N; Brogard JM
    Rev Med Interne; 1999 Aug; 20 Suppl 3():351s-359s. PubMed ID: 10480186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and oral sulfonylureas in the treatment of diabetes mellitus.
    White JR
    Am Pharm; 1992 Aug; NS32(8):39-43. PubMed ID: 1524021
    [No Abstract]   [Full Text] [Related]  

  • 10. Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening.
    Earle KE; Rushakoff RJ; Goldfine ID
    Diabetes Technol Ther; 2003; 5(3):449-51. PubMed ID: 12828829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exorcising the specter of nighttime hypoglycemia.
    Scheiner G
    Diabetes Self Manag; 2012; 29(1):16, 18-20. PubMed ID: 22482132
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypoglycemia with insulin and sulfonylureas.
    Kolman KB; Freeman J; Howe CL
    Can Fam Physician; 2020 May; 66(5):335. PubMed ID: 32404452
    [No Abstract]   [Full Text] [Related]  

  • 13. [Incidence of severe secondary effects during treatment with sulfonylureas and biguanides].
    Berger W
    Journ Annu Diabetol Hotel Dieu; 1986; ():243-53. PubMed ID: 3613372
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Viardot A
    Ther Umsch; 2017; 74(8):423-431. PubMed ID: 29461148
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypoglycaemia requiring medical assistance in patients with diabetes: a prospective multicentre survey in tertiary hospitals.
    Liatis S; Mylona M; Kalopita S; Papazafiropoulou A; Karamagkiolis S; Melidonis A; Xilomenos A; Ioannidis I; Kaltsas G; Lanaras L; Papas S; Basagiannis C; Kokkinos A
    Diabetes Metab; 2015 Apr; 41(2):126-31. PubMed ID: 25468446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas].
    Clerc D; Hugli O; Trueb L; Yersin B
    Rev Med Suisse; 2008 Aug; 4(167):1764-7. PubMed ID: 18800755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
    Francis M; Langhan T; Prosser J; Hoffman R
    Ann Emerg Med; 2008 Jun; 51(6):795-6; author reply 796-7. PubMed ID: 18489980
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypoglycemia in diabetes mellitus].
    Irsigler K
    Acta Med Austriaca; 1992; 19(4):100-5. PubMed ID: 1290316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part II--"The cons".
    Heine RJ
    Horm Metab Res; 1996 Sep; 28(9):522-6. PubMed ID: 8911991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphonylurea-induced hypoglycaemia in institutionalized elderly in Hong Kong.
    So WY; Chan JC; Yeung VT; Chow CC; Ko GT; Li JK; Cockram CS
    Diabet Med; 2002 Nov; 19(11):966-8. PubMed ID: 12421437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.